Attenuating human fear memory retention with minocycline: a randomized placebo-controlled trial
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Attenuating human fear memory retention with minocycline: a randomized placebo-controlled trial ; volume:14 ; number:1 ; day:17 ; month:1 ; year:2024 ; pages:1-8 ; date:12.2024
Translational Psychiatry ; 14, Heft 1 (17.1.2024), 1-8, 12.2024
- Urheber
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1038/s41398-024-02732-2
- URN
-
urn:nbn:de:101:1-2404230833463.837580494599
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.20252025, 01:46 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Xia, Yanfang
- Wehrli, Jelena
- Abivardi, Aslan
- Hostiuc, Madalina
- Kleim, Birgit
- Bach, Dominik R.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Correction: Attenuating human fear memory retention with minocycline: a randomized placebo-controlled trial
Minocycline attenuates interferon-α-induced impairments in rat fear extinction
Minocycline as adjunctive treatment for treatment-resistant depression: study protocol for a double blind, placebo-controlled, randomized trial (MINDEP2)
Minocycline for sporadic and hereditary cerebral amyloid angiopathy (BATMAN): study protocol for a placebo-controlled randomized double-blind trial
Adjuvant therapy with minocycline for schizophrenia (The MINOS Trial): study protocol for a double-blind randomized placebo-controlled trial
Specific intracellular retention of circSKA3 promotes colorectal cancer metastasis by attenuating ubiquitination and degradation of SLUG
Minocycline attenuates experimental subarachnoid hemorrhage in rats
Minocycline differentially modulates human spatial memory systems
Fasting enhances extinction retention and prevents the return of fear in humans
Prevention of hypoglycemia-induced neuronal death by minocycline
Treatment of bipolar depression with minocycline and/or aspirin: an adaptive, 2×2 double-blind, randomized, placebo-controlled, phase IIA clinical trial
Metformin reverse minocycline to inhibit minocycline-resistant Acinetobacter baumannii by destroy the outer membrane and enhance membrane potential in vitro
Correction: Attenuating human fear memory retention with minocycline: a randomized placebo-controlled trial
Minocycline attenuates interferon-α-induced impairments in rat fear extinction
Minocycline as adjunctive treatment for treatment-resistant depression: study protocol for a double blind, placebo-controlled, randomized trial (MINDEP2)
Minocycline for sporadic and hereditary cerebral amyloid angiopathy (BATMAN): study protocol for a placebo-controlled randomized double-blind trial
Adjuvant therapy with minocycline for schizophrenia (The MINOS Trial): study protocol for a double-blind randomized placebo-controlled trial
Specific intracellular retention of circSKA3 promotes colorectal cancer metastasis by attenuating ubiquitination and degradation of SLUG
Minocycline attenuates experimental subarachnoid hemorrhage in rats
Minocycline differentially modulates human spatial memory systems
Fasting enhances extinction retention and prevents the return of fear in humans
Prevention of hypoglycemia-induced neuronal death by minocycline
Treatment of bipolar depression with minocycline and/or aspirin: an adaptive, 2×2 double-blind, randomized, placebo-controlled, phase IIA clinical trial
Metformin reverse minocycline to inhibit minocycline-resistant Acinetobacter baumannii by destroy the outer membrane and enhance membrane potential in vitro
Correction: Attenuating human fear memory retention with minocycline: a randomized placebo-controlled trial
Minocycline attenuates interferon-α-induced impairments in rat fear extinction
Minocycline as adjunctive treatment for treatment-resistant depression: study protocol for a double blind, placebo-controlled, randomized trial (MINDEP2)
Minocycline for sporadic and hereditary cerebral amyloid angiopathy (BATMAN): study protocol for a placebo-controlled randomized double-blind trial
Adjuvant therapy with minocycline for schizophrenia (The MINOS Trial): study protocol for a double-blind randomized placebo-controlled trial
Specific intracellular retention of circSKA3 promotes colorectal cancer metastasis by attenuating ubiquitination and degradation of SLUG
Minocycline attenuates experimental subarachnoid hemorrhage in rats
Minocycline differentially modulates human spatial memory systems
Fasting enhances extinction retention and prevents the return of fear in humans
Prevention of hypoglycemia-induced neuronal death by minocycline
Treatment of bipolar depression with minocycline and/or aspirin: an adaptive, 2×2 double-blind, randomized, placebo-controlled, phase IIA clinical trial